Clearmind Medicine schedules annual and special shareholder meeting for December

Published 28/11/2025, 22:48
Clearmind Medicine schedules annual and special shareholder meeting for December

Clearmind Medicine Inc. (NASDAQ:CMND) announced Friday that it will hold its Annual and Special Meeting of Shareholders on Monday, December 29, 2025. The company’s board of directors has set November 20, 2025, as the record date for determining shareholders eligible to receive notice of and vote at the meeting.

According to a press release statement filed with the Securities and Exchange Commission, proxy materials for the meeting have been made available to shareholders. The filing includes a management information circular, a form of proxy card, a voting instruction form, and a financial statements request form.

Clearmind Medicine, a pharmaceutical company headquartered in Vancouver, British Columbia, stated that the meeting will address both annual and special matters, although specific agenda items were not detailed in the filing.

The information is based on a statement included in the company’s recent SEC filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.